Skip to search formSkip to main contentSkip to account menu

tedisamil

Known as: 3,7-di-(cyclopropylmethyl)-9,9-tetramethylene-3,7-diazabicyclo(3.3.1)nonane 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2001
Review
2001
Decreasing heart rate is potentially useful in ischaemic heart disease. Tedisamil is a bradycardic agent resulting from its… 
1998
1998
The modulation of the protein kinase A-activated chloride current (PKA-I[Cl]) may lead to modification of the cardiac action… 
1998
1998
The electrophysiologic and antifibrillatory properties of tedisamil (KC-8857) were studied in vivo in a conscious canine model of… 
Review
1997
Review
1997
The goal of developing an antiarrhythmic agent effective against malignant ventricular arrhythmias while maintaining a low side… 
1997
1997
Background: Tedisamil is a potent bradycardic/antiischemic drug known to lengthen car diac repolarization by blocking various… 
1996
1996
1 The direct cardiac electrophysiological and antifibrillatory actions of tedisamil (KC‐8857) were studied in rabbit isolated… 
Review
1994
Review
1994
1. Current positive inotropy therapy of heart failure is associated with major problems: digoxin and the phosphodiesterase… 
Highly Cited
1991
Highly Cited
1991
We examined the effects of tedisamil on ventricular fibrillation (VF) elicited by regional ischemia and by reperfusion in…